Self Administration of High Viscosity Drugs - Growth Driven by Advances in Biotechnology & Host-vector Engineering - Research and Markets

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/zztnpv/self) has announced the addition of the "Self Administration of High Viscosity Drugs" report to their offering.

Drug developers and device designers are increasingly working in collaboration to address the goal of patient self-administration for self injecting high viscosity drugs.

Growth in biological drugs has been driven by advances in biotechnology and host-vector engineering - advances that have led to a steady stream of biologics for a number of ailments and conditions. These powerful drugs come with a high cost-per-dose and the risk of significant side effects - factors that place an elevated emphasis on administration efficiency, safety and reliability.

Key Questions Answered:

  • Analyzes the market for therapeutic drugs with viscosities that cannot be delivered using standard patient self-injection devices and techniques.
  • Assesses technologies and devices that are aimed at positioning high viscosity drugs for patient self-administration, including injection devices and viscosity-lowering formulation techniques.
  • Analyzes design factors, material selection issues, formulation factors, and device capabilities and limitations.
  • Profiles injectable drug and device participants, their product development activities, business strategies, and corporate alliances and affiliations.
  • Evaluates key therapeutic sectors for high viscosity injectables.
  • Provides market data and forecasts to 2020.
  • Evaluates the impact of economic, technology, and regulatory factors on self-injecting high viscosity drugs.

Report Structure:

1. Executive Summary

2. The Market Opportunity

3. The Economics of Injectable Drugs

4. High Viscosity Injection Devices - Design Factors

5. Drug Properties (T/C/V)

6. High Viscosity Injection - Device Analysis

7. Specialty Autoinjectors

8. High Viscosity Injectables - the Current Market

9. Combination Products

10. High Viscosity Injectables - Key Therapeutic Sector Analysis

11. Therapy Sectors

12. Market Factors

13. Regulatory Initiatives

For more information visit http://www.researchandmarkets.com/research/zztnpv/self

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Drug Delivery

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Drug Delivery